All articles by Anthony King
-
Research
How HIV drugs have changed over the decades
From one big pill that only prolonged lives a few months, through the 20 pills a day years to modern combination therapies, treating HIV is a science success story
-
Research
Microbial enzymes cut a path towards universal blood for transfusions
Slicing off glycans revealed new, previously unknown antigens that must be removed to produce O-type blood
-
News
Plastic chemicals review reveals thousands of compounds have little safety data
Existing scientific knowledge on hazards of plastic chemicals compiled in dossier for decision makers
-
Research
Concerns raised over health effects of chemicals leaching from food packaging
Gene assays reveal disruption to cell receptors crucial for hormonal and metabolic control
-
Feature
How microbes influence our brain health
Our gut microbiome has been linked to conditions such as Parkinson’s and Alzheimer’s. Anthony King reports on the connections
-
Business
Chemours suspends chief and senior executives over accounting issues
Auditors to investigate issues around whistleblowing and financial management
-
Business
Big deals confirm renewed interest in radiopharmaceuticals
Acquisitions of RayzeBio and Point Biopharma highlight the potential of targeting radioactivity directly to tumour cells
-
Research
Striking reptilian fossil discovered in 1931 found to be fake
280-million-year-old lizard ‘fossil’ was mostly painted on
-
Business
Novo Holdings to buy contract manufacturer Catalent for $16.5 billion
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
-
Research
Rare medical transmission of Alzheimer’s disease from donor to patient discovered
Human growth hormone extracted from cadavers passed disease protein to at least five people
-
Business
Nuclear power expansion plans highlight fuel bottlenecks
Western governments look to overcome Russian dominance of key uranium processing steps
-
Business
Danaher completes $5.7 billion Abcam acquisition
Deal proceeded despite significant opposition from founder and ex-chief Jonathan Milner
-
Business
Life-saving cancer gene therapy under investigation after being linked to rare secondary cancers
US drug agency examining six CAR-T therapies after reports of T-cell malignancies
-
Business
Northvolt to bring sodium-ion batteries to European market
Swedish firm highlights cells’ cheap and sustainable materials for energy storage
-
Business
Weight-loss drug shortages prompt copycats and counterfeits
Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments
-
News
Irish PhD researchers left disappointed as stipend raise is just half of what was hoped for
Independent review recommended increasing stipends to €25,000 but they rose to just €22,000
-
Research
Field study reveals banned pesticide sulfoxaflor had no effect on pollination by bumblebees
Work adds to nuanced picture of pesticide’s effect on pollinating insects
-
Research
Genetic-editing of chickens protects them from catching the flu
Approach heralds new way to make animals resistant to disease
-
Research
Mutation studies reveal how Antarctic octopus arms itself with cool enzyme
Understanding cold-tolerant enzyme could help with transplant organ preservation
-
Research
’This is just the beginning’: RNA editing set to democratise viral engineering
Crispr-based system could ease development of novel RNA therapies